Nav: Home

'Specialty medical home' seeks to provide patient-centered care for patients with inflammatory bowel diseases

May 04, 2016

May 4, 2016 - A specialty medical home--providing expert medical care coordinated with attention to social support and mental health--is a promising new approach to patient-centered, cost-effective care for patients with Crohn's disease and ulcerative colitis, according to a special "Future Directions" paper in the May issue of Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America (CCFA). The journal is published by Wolters Kluwer.

The inflammatory bowel diseases specialty medical home (IBD SMH) is "a new model of care that places the patient at the center of the medical universe," write Dr. Miguel D. Regueiro and colleagues of University of Pittsburgh Medical Center and UPMC Health Plan. They share their institution's experience with developing a specialty medical home to provide comprehensive care for IBD.

Specialty Medical Home Approach for Coordinated Care of IBD

The "patient-centered medical home" has emerged as a new model to improve coordination of healthcare services while controlling costs. So far, most studies of this approach have focused on primary care settings, with mixed results in terms of patient outcomes and healthcare spending.

But for patients with IBD, most care is provided by gastroenterologists and other specialists. "Clinicians who care for these patients recognize that this population requires specialized and personalized care," Dr. Regueiro and coauthors write.

Created in collaboration between healthcare providers and payers, the IBD SMH focuses on providing "high-quality, comprehensive, cost-effective, patient-centered care" for Crohn's disease and ulcerative colitis. While this approach can potentially improve care for all patients, it focuses on the relatively small group who incur disproportionately high costs. Specialists at UPMC found that 14 percent of patients accounted for nearly half of spending for IBD care.

The IBD SMH seeks to address the high rates of emotional difficulties, pain, and poor social support experienced by these "high utilizers." Dr. Regueiro and colleagues explain that pain, stress, coping problems, anxiety, depression, and fatigue can all affect the disease process in IBD--contributing to worsened inflammation and increased healthcare needs.

In addition to optimizing medical and surgical care, the specialty medical home approach aims to enhance behavioral skills, improve social support, and reduce stress. Care is provided by a team including gastroenterologists and personal nurse coordinators, as well as surgeons, behavioral health and pain specialists, dietitians, and other professionals.

Key aspects of the specialty medical home approach include an IBD Patient Checklist to ensure that all recommended preventive care steps are followed; individualized psychological care, addressing the "brain-gut" connection by which stress, anxiety, and depression can lead to worsening of IBD; optimal approaches to pain management, including evidence-based nondrug approaches; and nutritional support to address the special dietary needs of people with IBD.

Dr. Regueiro and colleagues believe the SMH IBD can provide "patient-centered care that improves the value and quality of the medical experience while reducing cost." They hope their experience will be helpful to other medical centers interested in developing specialty medical homes, for IBD or other chronic diseases requiring specialist care.

But the authors emphasize that many challenges remain in optimizing the care provided by the IBD SMH and demonstrating its benefits in terms of improved patient care and reduced costs. Dr. Regueiro and colleagues conclude, "The future of healthcare will rely on chronic care models that have yet to be realized, and the gastroenterologist will play a central role in the IBD management paradigm of tomorrow."

Crohn's disease is a painful, medically incurable illness that may cause inflammation anywhere along the digestive system. Crohn's disease and ulcerative colitis, which involves only the large intestine (colon), are the two main types of inflammatory bowel diseases. Some 1.6 million American adults and children suffer from Crohn's disease or ulcerative colitis.
-end-
Click here to read "The Inflammatory Bowel Disease Specialty Medical Home: A New Model of Patient-centered Care."

Article: "The Inflammatory Bowel Disease Specialty Medical Home: A New Model of Patient-centered Care" (doi: 10.1097/MIB.0000000000000819)

Note to editors: For further information, contact Erin Stoeber, Vice President of Marketing & Communications for the CCFA: phone 347-899-5479 or e-mail estoeber@ccfa.org">estoeber@ccfa.org.

About Inflammatory Bowel Diseases

Inflammatory Bowel Diseases brings the most current information in clinical and basic sciences to physicians caring for patients with inflammatory bowel diseases, and investigators performing research in IBD and related fields. Each issue contains cutting-edge original basic science and clinical articles on diagnosis, treatment, and management of IBD from clinicians and researchers around the world. Coverage includes articles highlighting the unique and important issues in pediatric IBD, as well as articles pertaining to adult patients.

About CCFA

The Crohn's & Colitis Foundation of America (CCFA) is the largest voluntary non-profit health organization dedicated to finding cures for Inflammatory Bowel Diseases (IBD). CCFA's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research, providing educational resources for patients and their families, medical professionals, and the public, and furnishing supportive services for those afflicted with IBD. For more information, visit http://www.ccfa.org, call 888-694-8872, like us on Facebook, or follow us on Twitter.

About Wolters Kluwer

Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information about our products and organization, visit http://www.wolterskluwerhealth.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

Wolters Kluwer Health

Related Ulcerative Colitis Articles:

Walnuts show protection against ulcerative colitis in early study
Through their complex array of natural compounds and phytochemicals, walnuts provide a multitude of health benefits.
The impacts of smoking on patients with ulcerative colitis
Because smokers are less likely to develop ulcerative colitis (UC), a type of inflammatory bowel disease, patients with UC may be tempted to start smoking to lessen their symptoms.
New method divides patients with ulcerative colitis in groups
Researchers at Karolinska Institutet in Sweden have found a way of using gene expression conserved across species to divide patients with the inflammatory bowel disease ulcerative colitis into two distinct groups.
Potential new therapy for Crohn's, colitis identified
Researchers at Washington University School of Medicine in St. Louis have found a compound that may treat inflammatory bowel disease without directly targeting inflammation.
Emerging therapies show benefit to patients with Crohn's disease and ulcerative colitis
It is estimated that 3 million Americans live with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis.
More Ulcerative Colitis News and Ulcerative Colitis Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...